Venlafaxine Hydrochloride
Product Images NDC 67046-406

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 67046-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A pharmacokinetic chart showing the fold change in Cmax and AUC of venlafaxine with various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The chart presents 90% confidence interval recommendations for dose adjustments or cautions relative to these drug interactions.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic fold change chart showing interactions between Venlafaxine Hydrochloride and various drugs. The chart lists interacting drugs, analytes (such as ethanol, diazepam, alprazolam), and PK parameters (Cmax, AUC) on the left. On the right, it depicts fold changes with 90% confidence intervals, accompanied by recommendations like 'No dose adjustment,' 'Avoid concomitant use,' or 'Clinical significance unknown.' The x-axis represents the change relative to the reference value, ranging from 0 to 3.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A clinical pharmacokinetic chart depicting fold change and 90% confidence intervals for venlafaxine in various special populations including hepatic (cirrhosis, mild, moderate impairment), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism metabolizers, age over 60 years, and gender. It includes pharmacokinetic parameters such as Cmax, AUC, and ODV, with dosing recommendations displayed alongside for each population subgroup.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing the arrangement of its molecular groups, including a dimethylaminoethyl group, a methoxyphenyl ring, and a cyclohexanol moiety, with the hydrochloride salt indicated.*

FDA Label Image

V150 (Venlfax150mg.406)

Label for Venlafaxine Hydrochloride extended release capsules, 150 mg strength. The label indicates 30 capsules per container and is marked RX only. Storage instructions specify controlled room temperature (20° to 25°C). The product is packaged by Contract Pharmacy Services-PA, located in Warrington, Pennsylvania. Lot number and expiration date are visible, along with barcodes.*

FDA Label Image

V75 (Venlfax75mg.320)

Label for Venlafaxine ER 75 mg extended release capsules, bottle of 30 capsules. The label includes medication storage instructions, barcodes, lot number HR7520021-A, expiration date 03/15/2021, pill ID E74, and the labeler Contract Pharmacy Services-PA with address in Warrington, PA. The label states the capsule contains venlafaxine hydrochloride equivalent to 75 mg venlafaxine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.